
Topic
Payer Policy
Medicare, commercial payer, PBM, and formulary-policy moves that shape launch curves and gross-to-net.

Pricing & Access· May 20, 2026 · 10 min read
By Ran Chen#GLP-1#Coverage Access#Prior Authorization

Biosimilars· May 20, 2026 · 11 min read
Stelara biosimilars: FDA status, interchangeability, payer coverage, and switching

Pricing & Access· May 19, 2026 · 15 min read
Humira coverage guide: formularies, biosimilars, prior authorization, assistance
By Ran Chen#Immunology#Prior Authorization#Payer Policy

Pricing & Access· May 19, 2026 · 17 min read
Rinvoq vs Humira: label, access, and payer coverage compared
By Ran Chen#Immunology#Prior Authorization#Payer Policy

Pricing & Access· May 19, 2026 · 11 min read
Skyrizi vs Stelara: label, access, and payer coverage compared
By Ran Chen#Immunology#Prior Authorization#Payer Policy

Pricing & Access· May 18, 2026 · 11 min read
Jardiance vs Farxiga: label, access, and payer coverage compared

Pricing & Access· May 18, 2026 · 13 min read
Rinvoq coverage guide: formularies, JAK safety, prior authorization, assistance
By Ran Chen#Immunology#Prior Authorization#Payer Policy

Pricing & Access· May 18, 2026 · 11 min read
Stelara coverage guide: formularies, biosimilars, prior authorization, assistance
By Ran Chen#Immunology#Prior Authorization#Payer Policy

Pricing & Access· May 17, 2026 · 11 min read
Dupixent coverage guide: formulary, prior authorization, and patient assistance

Pricing & Access· May 16, 2026 · 11 min read
Eliquis vs Xarelto: label, access, and payer coverage compared
By Ran Chen#DOAC#Anticoagulant#Prior Authorization